ATP and UTP activate calcium-mobilizing P(2U)-like receptors and act synergistically with interleukin-1 to stimulate prostaglandin E2 release from human rheumatoid synovial cells

Arthritis and Rheumatism

Volumn 41, Issue 2, 1998, Pages 246-255

  Loredo, Grace A ^a   Benton, Hilary P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; INTERLEUKIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; PURINE P2Y2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RECOMBINANT INTERLEUKIN 1ALPHA; THAPSIGARGIN; URIDINE TRIPHOSPHATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TISSUE INJURY;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; BUFFERS; CALCIUM; DINOPROSTONE; DRUG SYNERGISM; HUMANS; INTERLEUKIN-1; MIDDLE AGED; RECEPTORS, PURINERGIC; SYNOVIAL MEMBRANE; TETRADECANOYLPHORBOL ACETATE; THAPSIGARGIN; URIDINE TRIPHOSPHATE;

EID: 0031936693     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199802)41:2<246::AID-ART8>3.0.CO;2-I     Document Type: Article

References (62)

1. Allard SA, Bayliss MT, Maini RN. The synovium-cartilage junction of the normal human knee: implications for joint destruction and repair. Arthritis Rheum 1990;33:1170-9.
2. Lotz M, Blanco FJ, Kempis JV, Dudler J, Maier R, Villiger PM, et al. Cytokine regulation of chondrocyte functions. J Rheumatol 1995;22:104-8.
3. Pelletier J-P, DiBattista JA, Roughley P, McCollum R, Martel-Pelletier J. Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 1993;19:545-61.
4. Hardingham T, Bayliss M, Rayan V, Noble D. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage. Br J Rheumatol 1992;31:1-6.
5. Benton H, Tyler J. Inhibition of cartilage proteoglycan synthesis by interleukin 1. Biochem Biophys Res Comm 1988;154:421-8.
6. Benton H, O'Mahony A. Signal transduction from cytokine receptors. In: Lad P, Kaptein J, Lin C-K, editors. Signal transduction in leukocytes: G-protein related and other pathways. Boca Raton (FL): CRC Press; 1996. p. 5-35.
7. Fam A. Calcium pyrophosphate crystal deposition disease and other crystal deposition diseases. Curr Opin Rheumatol 1992;4: 574-82.
8. Ryan LM, Rachow JW, McCarty DJ. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. J Rheumatol 1991;18:716-20.
9. Gordon J. Extracellular ATP: effects, sources and fate. Biochem J 1986;233:309-19.
10. Walz W, Ilschner S, Ohlemeyer C, Banati R, Kettenmann H. Extracellular ATP activates a cation conductance and a K+ conductance in cultured microglial cells from mouse brain. Neuroscience 1993;13:4403-11.
11. Griffiths RJ, Stam EJ, Downs JT, Otterness IG. ATP induces the release of IL-1 from LPS-primed cells in vivo. J Immunol 1995; 154:2821-8.
12. El-Moatassim C, Dornand J, Mani J-C. Extracellular ATP and cell signaling. Biochim Biophys Acta 1992;1134:31-45.
13. Huang NN, Wang DJ, Gonzalez F, Heppel LA. Multiple signal transduction pathways lead to extracellular ATP-stimulated mitogenesis in mammalian cells: a pathway involving arachidonic acid release, prostaglandin synthesis, and cyclic AMP accumulation. J Cell Physiol 1991;146:483-94.
14. Lazarowski ER, Boucher RC, Harden TK. Calcium-dependent release of arachidonic acid in response to purinergic receptor activation in airway epithelium. Am J Physiol 1994;266:C406-15.
15. Koolpe M, Benton HP. Calcium-mobilizing purine receptors on the surface of mammalian articular chondrocytes. J Orthop Res 1997;15:204-13.
16. Burnstock G. Overview: purinergic mechanisms. In: Dubyak GR, Fedan JS, editors. Biological actions of extracellular ATP. New York: The New York Academy of Sciences; 1990.
17. Conigrave A, Jiang L. Review: Ca2+-mobilizing receptors for ATP and UTP. Cell Calcium 1995;17:111-9. p. 1-17.
18. Harden TK, Boyer JL, Nicholas RA. P2-purinergic receptors: subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol 1995;35:541-79.
19. Boeynaems JM, Communi D, Pirotton S, Motte S, Parmentier M. Involvement of distinct receptors in the actions of extracellular uridine nucleotides. Ciba Found Symp 1996;198:266-74.
20. 2Y purinoceptors. Ciba Found Symp 1996;198: 166-80.
21. 2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP-and UTP-specific receptor. Mol Pharmacol 1996;50: 224-9.
22. 2 release in response to bradykinin. J Immunol 1989;143:579-86.
23. Bathon JM, Croghan JE, Goldman DW, MacGlashan DW, Proud D. Modulation of kinin responses in human synovium by interleukin-1. Agents Actions 1992;38 Suppl 2:16-22.
24. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
25. Pugh-Humphreys RGP, Thomson AW. Cytokines and their receptors as potential therapeutic targets. In: Thomson A, editor. The cytokine handbook. San Diego: Academic Press Limited; 1994. p. 525-66.
26. Westacott CI, Whicher JT, Barnes IC, Thompson D, Swan AJ. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 1990;49:676-81.
27. Benton HP, Jackson TR, Hanley MR. Identification of a novel inflammatory stimulant of chondrocytes. Biochem J 1989;258: 861-7.
28. Müller-Ladner U, Gray RE, Gay S. Structure and function of synoviocytes. In: Koopman WJ, editor. Arthritis and allied conditions. Baltimore: Williams & Wilkins; 1997. p. 243-54.
29. Hardingham T. Biosynthesis, assembly and turnover of cartilage proteoglycans. In: Glauert A, editor. The control of tissue damage. New York: Elsevier; 1988. p. 41-52.
30. Tyler J. The influence of interleukin 1 and insulin-like growth factor 1 on the integrity of cartilage matrix. In: Glauert A, editor. The control of tissue damage. New York: Elsevier; 1988. p. 197-214.
31. 2 production by human synovial cells. J Clin Invest 1986;77:645-8.
32. Chevalier X. Upregulation of enzymatic activity by interleukin-1 in osteoarthritis. Biomed Pharmacother 1997;51:58-62.
33. Knott I, Dieu M, Burton M, Houbion A, Remacle J, Raes M. Induction of cyclooxygenase by interleukin 1: comparative study between human synovial cells and chondrocytes. J Rheumatol 1994;21:462-6.
34. Wittenberg RH, Willburger RE, Kleemeyer KS, Peskar BA. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum 1993;36:1444-50.
35. Cisar LA, Mochan E, Schimmel R. Interleukin-1 selectively potentiates bradykinin-stimulated arachidonic acid release from human synovial fibroblasts. Cell Signal 1993;5:463-72.
36. Cheng T-C, Benton H. The intracellular Ca2+-pump inhibitors thapsigargin and cyclopiazonic acid induce stress proteins in mammalian chondrocytes. Biochem J 1994;301:563-8.
37. Grynkiewicz G, Poenie M, Tsien R. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
38. Lowry ON, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193: 265-75.
39. Lotz M. Cytokines and their receptors. In: Koopman WJ, editor. Arthritis and allied conditions. Baltimore: Williams & Wilkins; 1997. p. 439-78.
40. Harris ED Jr. Cytokines, lymphokines, growth factors, and chemokines. In: Rheumatoid Arthritis. Philadelphia: WB Saunders; 1997. p 105-21.
41. Jasin HE. Mechanisms of tissue damage in rheumatoid arthritis. In: Koopman WJ, editor. Arthritis and allied conditions. Baltimore: Williams & Wilkins; 1997. p. 1017-39.
42. Nguyen T, Erb L, Weisman G, Marchese A, Heng H, Garrad R, et al. Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene. J Biol Chem 1995;270: 30845-8.
43. Communi D, Pirotton S, Parmentier M, Boeynaems J. Cloning and functional expression of a human uridine nucleotide receptor. J Biol Chem 1995;270:30849-52.
44. Blake A, Julius D. Signaling by extracellular nucleotides. Annu Rev Cell Develop Biol 1996;12:519-41.
45. Putney JJ. A model for receptor-regulated calcium entry. Cell Calcium 1986;7:1-12.
46. Cush JJ, Lipsky PE. The immunopathogenesis of rheumatoid arthritis: the role of cytokines in chronic inflammation. Clin Aspects Autoimmunol 1987;1:2-13.
47. Kang RY, Freire-Moar J, Sigal E, Chu C-Q. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br J Rheumatol 1996;35:711-8.
48. Robinson DR, Armen H, Tashjian J, Levine L. Prostaglandin-stimulated bone resorption by rheumatoid synovia. J Clin Invest 1975;56:1181-8.
49. Dayer J-M, Krane SM, Russell RGG, Robinson DR. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci U S A 1976;73:945-9.
50. Salmon JA, Higgs GA, Vane JR, Bitensky L, Chayen J, Henderson B, et al. Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture. Ann Rheum Dis 1983;42:36-9.
51. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin 1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-7.
52. Robinson DR. Lipid mediators of inflammation. Rheum Dis Clin North Am 1987;13:385-405.
53. Lowe GN, Fu Y-H, McDougall S, Polendo R, Williams A, Benya PD, et al. Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers. Endocrinology 1996;137:2208-16.
54. Geng Y, Blanco FJ, Cornelisson M, Lotz M. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol 1995;155:796-801.
55. 2-purinoceptors at the surface of human articular chondrocytes in monolayer culture. Biochim Biophys Acta 1991;1074:151-8.
56. Lytton J, Westlin M, Hanley M. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 1991;266:17067-71.
57. Kijima Y, Ogunmunmi E, Fleischer S. Drug action of thapsigargin on the Ca2+ pump protein of sarcoplasmic reticulum. J Biol Chem 1991;266:22912-8.
58. Thastrup O, Cullen P, Drobak B, Hanley M, Dawson A. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci U S A 1990;87:2466-70.
59. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984;308:693-8.
60. Bathon JM, Manning DC, Goldman DW, Towns MC, Proud D. Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J Pharmacol Exp Ther 1992;260:384-92.
61. Born GVR, Kratzer MAA. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol 1984;354:419-29.
62. 2U purinergic receptor. Proc Natl Acad Sci U S A 1993:90:10449-53.